UHC will expose almost $1B in lost revenues over the next year and a half. PAMA has affected reimbursements. All of these factors force LCA executives to scramble to save the dwindling stock price.
Cutting costs is an easy fix, yet it will translate into customer frustration, further exposing revenue erosion going forward.
Quest and LabCorp need to slowly adjust their business model to face the harsh realities of modern healthcare. Unfortunately, it will come at the expense of the employees.